Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,160,486
  • Shares Outstanding, K 49,215
  • Annual Sales, $ 4,050 M
  • Annual Income, $ 22,200 K
  • EBIT $ 555 M
  • EBITDA $ 1,132 M
  • 60-Month Beta 1.61
  • Price/Sales 2.80
  • Price/Cash Flow 10.06
  • Price/Book 3.15

Options Overview Details

View History
  • Implied Volatility 46.53% (+4.17%)
  • Historical Volatility 28.68%
  • IV Percentile 68%
  • IV Rank 26.43%
  • IV High 86.39% on 04/11/25
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 29) 20.87 (9.31%)
  • Put/Call Vol Ratio 0.44
  • Today's Volume 167
  • Volume Avg (30-Day) 756
  • Put/Call OI Ratio 1.40
  • Today's Open Interest 5,351
  • Open Int (30-Day) 5,253
  • Expected Range 203.16 to 244.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.33
  • Number of Estimates 7
  • High Estimate 2.36
  • Low Estimate 2.31
  • Prior Year 2.66
  • Growth Rate Est. (year over year) -12.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
194.93 +14.93%
on 01/05/26
228.88 -2.12%
on 01/13/26
+21.01 (+10.35%)
since 12/22/25
3-Month
156.72 +42.95%
on 11/19/25
228.88 -2.12%
on 01/13/26
+37.03 (+19.80%)
since 10/22/25
52-Week
91.86 +143.88%
on 04/11/25
228.88 -2.12%
on 01/13/26
+55.81 (+33.18%)
since 01/22/25

Most Recent Stories

More News
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2025 financial results and provide 2026 guidance on Wednesday, February 18 th , before...

CRL : 224.03 (-1.21%)
Charles River Enters Manufacturing Collaboration with Gazi University

Cell and Gene Therapy CDMO to bolster rare disease research at Gazi University Faculty of Medicine

CRL : 224.03 (-1.21%)
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

NEW YORK and NEW ORLEANS , Jan. 20, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC ("KSF"), announces...

CRL : 224.03 (-1.21%)
What to Expect From Charles River Laboratories’ Next Quarterly Earnings Report

Charles River Laboratories is scheduled to report its fiscal fourth-quarter results shortly, with analysts forecasting a low–double-digit year-over-year decline in earnings.

XLV : 158.29 (+0.02%)
$SPX : 6,913.35 (+0.55%)
CRL : 224.03 (-1.21%)
Charles River Laboratories Provides Business Updates

– Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in...

CRL : 224.03 (-1.21%)
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

– Jim Foster, Chair, President & CEO, Announces Plans to Retire at the 2026 Annual Meeting of Shareholders in May 2026 After Distinguished 50-Year...

CRL : 224.03 (-1.21%)
3 Overrated Stocks We Steer Clear Of

3 Overrated Stocks We Steer Clear Of

RPRX : 40.11 (+0.98%)
LASR : 48.00 (+4.48%)
CRL : 224.03 (-1.21%)
3 Low-Volatility Stocks We Think Twice About

3 Low-Volatility Stocks We Think Twice About

ITGR : 85.54 (-1.68%)
BKD : 12.74 (+1.51%)
CRL : 224.03 (-1.21%)
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds

1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds

ADSK : 269.77 (+4.79%)
CDNS : 317.09 (+1.04%)
CRL : 224.03 (-1.21%)
Why Charles River Laboratories (CRL) Stock Is Trading Up Today

Why Charles River Laboratories (CRL) Stock Is Trading Up Today

CRL : 224.03 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 233.60
2nd Resistance Point 230.99
1st Resistance Point 227.51
Last Price 224.03
1st Support Level 221.43
2nd Support Level 218.82
3rd Support Level 215.34

See More

52-Week High 228.88
Last Price 224.03
Fibonacci 61.8% 176.54
Fibonacci 50% 160.37
Fibonacci 38.2% 144.20
52-Week Low 91.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar